Angela J Lee
Examiner (ID: 6328, Phone: (571)272-4453 , Office: P/2911 )
Most Active Art Unit | 2911 |
Art Unit(s) | 2911 |
Total Applications | 4552 |
Issued Applications | 4511 |
Pending Applications | 11 |
Abandoned Applications | 25 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8290376
[patent_doc_number] => 20120178691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/423031
[patent_app_country] => US
[patent_app_date] => 2012-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 116915
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13423031
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/423031 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME | Mar 15, 2012 | Abandoned |
Array
(
[id] => 8290376
[patent_doc_number] => 20120178691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/423031
[patent_app_country] => US
[patent_app_date] => 2012-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 116915
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13423031
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/423031 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME | Mar 15, 2012 | Abandoned |
Array
(
[id] => 6189786
[patent_doc_number] => 20110172147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/072048
[patent_app_country] => US
[patent_app_date] => 2011-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35599
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20110172147.pdf
[firstpage_image] =>[orig_patent_app_number] => 13072048
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/072048 | NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS | Mar 24, 2011 | Abandoned |
Array
(
[id] => 8336055
[patent_doc_number] => 20120202754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'ENHANCED SUBSTRATES FOR THE PROTEASE ACTIVITY OF SEROTYPE A BOTULINUM NEUROTOXIN'
[patent_app_type] => utility
[patent_app_number] => 13/502504
[patent_app_country] => US
[patent_app_date] => 2010-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10249
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502504
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/502504 | ENHANCED SUBSTRATES FOR THE PROTEASE ACTIVITY OF SEROTYPE A BOTULINUM NEUROTOXIN | Oct 14, 2010 | Abandoned |
Array
(
[id] => 6071208
[patent_doc_number] => 20110046059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS'
[patent_app_type] => utility
[patent_app_number] => 12/842386
[patent_app_country] => US
[patent_app_date] => 2010-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17278
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046059.pdf
[firstpage_image] =>[orig_patent_app_number] => 12842386
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/842386 | PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS | Jul 22, 2010 | Abandoned |
Array
(
[id] => 6579435
[patent_doc_number] => 20100273977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'PROCESS FOR THE PREPARATION OF ECHINOCANDIN DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/830941
[patent_app_country] => US
[patent_app_date] => 2010-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7283
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273977.pdf
[firstpage_image] =>[orig_patent_app_number] => 12830941
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/830941 | PROCESS FOR THE PREPARATION OF ECHINOCANDIN DERIVATIVES | Jul 5, 2010 | Abandoned |
Array
(
[id] => 6395834
[patent_doc_number] => 20100304363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'PEPTIDE COMPOUNDS FOR DETECTING OR INHIBITING SARS CORONAVIRUS AND APPLICATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/787508
[patent_app_country] => US
[patent_app_date] => 2010-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3595
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20100304363.pdf
[firstpage_image] =>[orig_patent_app_number] => 12787508
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/787508 | PEPTIDE COMPOUNDS FOR DETECTING OR INHIBITING SARS CORONAVIRUS AND APPLICATION THEREOF | May 25, 2010 | Abandoned |
Array
(
[id] => 7685102
[patent_doc_number] => 20100121039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'METHODS AND COMPOSITIONS FOR PROLONGING ELIMINATION HALF-TIMES OF BIOACTIVE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/606055
[patent_app_country] => US
[patent_app_date] => 2009-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19812
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20100121039.pdf
[firstpage_image] =>[orig_patent_app_number] => 12606055
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/606055 | METHODS AND COMPOSITIONS FOR PROLONGING ELIMINATION HALF-TIMES OF BIOACTIVE COMPOUNDS | Oct 25, 2009 | Abandoned |
Array
(
[id] => 6593807
[patent_doc_number] => 20100048476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'NOVEL USE OF BACTERIOCIN DERIVED FROM ENTEROCOCCUS FAECALIS SL-5'
[patent_app_type] => utility
[patent_app_number] => 12/482093
[patent_app_country] => US
[patent_app_date] => 2009-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4150
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048476.pdf
[firstpage_image] =>[orig_patent_app_number] => 12482093
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/482093 | NOVEL USE OF BACTERIOCIN DERIVED FROM ENTEROCOCCUS FAECALIS SL-5 | Jun 9, 2009 | Abandoned |
Array
(
[id] => 6025795
[patent_doc_number] => 20110053851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'HAEMOSTASIS-MODULATING COMPOSITIONS AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/808356
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24175
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053851.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808356
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808356 | HAEMOSTASIS-MODULATING COMPOSITIONS AND USES THEREFOR | Dec 17, 2008 | Abandoned |
Array
(
[id] => 5570257
[patent_doc_number] => 20090253635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'PEPTIDES AND PEPTIDOMIMETICS HAVING ANTI-PROLIFERATIVE ACTIVITY AND/OR THAT AUGMENT NUCLEIC ACID DAMAGING AGENTS OR TREATMENTS'
[patent_app_type] => utility
[patent_app_number] => 12/328632
[patent_app_country] => US
[patent_app_date] => 2008-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 25453
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253635.pdf
[firstpage_image] =>[orig_patent_app_number] => 12328632
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/328632 | PEPTIDES AND PEPTIDOMIMETICS HAVING ANTI-PROLIFERATIVE ACTIVITY AND/OR THAT AUGMENT NUCLEIC ACID DAMAGING AGENTS OR TREATMENTS | Dec 3, 2008 | Abandoned |
Array
(
[id] => 5331258
[patent_doc_number] => 20090111735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'Compounds and methods for reducing undesired toxicity of chemotherapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 12/283995
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 24631
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111735.pdf
[firstpage_image] =>[orig_patent_app_number] => 12283995
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/283995 | Compounds and methods for reducing undesired toxicity of chemotherapeutic agents | Sep 16, 2008 | Abandoned |
Array
(
[id] => 7697137
[patent_doc_number] => 20110229453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'BLOOD COAGULATION FACTOR INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/674305
[patent_app_country] => US
[patent_app_date] => 2008-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18480
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229453.pdf
[firstpage_image] =>[orig_patent_app_number] => 12674305
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/674305 | BLOOD COAGULATION FACTOR INHIBITORS | Aug 18, 2008 | Abandoned |
Array
(
[id] => 5502725
[patent_doc_number] => 20090163413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'DENTAL PRODUCTS COMPRISING BONE GROWTH ENHANCING PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 12/108374
[patent_app_country] => US
[patent_app_date] => 2008-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5836
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163413.pdf
[firstpage_image] =>[orig_patent_app_number] => 12108374
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/108374 | DENTAL PRODUCTS COMPRISING BONE GROWTH ENHANCING PEPTIDE | Apr 22, 2008 | Abandoned |
Array
(
[id] => 4916223
[patent_doc_number] => 20080096824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'KU-70-DERIVED BAX-SUPPRESSING PEPTIDES AND USE THEREOF FOR THE PROTECTION OF DAMAGED CELLS'
[patent_app_type] => utility
[patent_app_number] => 11/862504
[patent_app_country] => US
[patent_app_date] => 2007-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7526
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096824.pdf
[firstpage_image] =>[orig_patent_app_number] => 11862504
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/862504 | KU-70-DERIVED BAX-SUPPRESSING PEPTIDES AND USE THEREOF FOR THE PROTECTION OF DAMAGED CELLS | Sep 26, 2007 | Abandoned |
Array
(
[id] => 4894002
[patent_doc_number] => 20080103101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'KU-70-DERIVED BAX-SUPPRESSING PEPTIDES AND USE THEREOF FOR THE PROTECTION OF DAMAGED CELLS'
[patent_app_type] => utility
[patent_app_number] => 11/862560
[patent_app_country] => US
[patent_app_date] => 2007-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7593
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20080103101.pdf
[firstpage_image] =>[orig_patent_app_number] => 11862560
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/862560 | KU-70-DERIVED BAX-SUPPRESSING PEPTIDES AND USE THEREOF FOR THE PROTECTION OF DAMAGED CELLS | Sep 26, 2007 | Abandoned |
Array
(
[id] => 6252324
[patent_doc_number] => 20100028407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'LAYERED BIO-ADHESIVE COMPOSITIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/298698
[patent_app_country] => US
[patent_app_date] => 2007-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15147
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028407.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298698
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298698 | LAYERED BIO-ADHESIVE COMPOSITIONS AND USES THEREOF | Apr 23, 2007 | Abandoned |
Array
(
[id] => 5091661
[patent_doc_number] => 20070231300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'COVALENT CONJUGATES BETWEEN ENDOPEROXIDES AND TRANSFERRIN AND LACTOFERRIN RECEPTOR-BINDING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 11/692866
[patent_app_country] => US
[patent_app_date] => 2007-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15898
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231300.pdf
[firstpage_image] =>[orig_patent_app_number] => 11692866
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/692866 | COVALENT CONJUGATES BETWEEN ENDOPEROXIDES AND TRANSFERRIN AND LACTOFERRIN RECEPTOR-BINDING AGENTS | Mar 27, 2007 | Abandoned |
Array
(
[id] => 5534309
[patent_doc_number] => 20090234097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'VASODILATOR'
[patent_app_type] => utility
[patent_app_number] => 12/279218
[patent_app_country] => US
[patent_app_date] => 2007-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2691
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20090234097.pdf
[firstpage_image] =>[orig_patent_app_number] => 12279218
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/279218 | VASODILATOR | Feb 13, 2007 | Abandoned |
Array
(
[id] => 5272129
[patent_doc_number] => 20090075905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Anticancer compounds and methods'
[patent_app_type] => utility
[patent_app_number] => 11/635097
[patent_app_country] => US
[patent_app_date] => 2006-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14554
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075905.pdf
[firstpage_image] =>[orig_patent_app_number] => 11635097
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/635097 | Anticancer compounds and methods | Dec 6, 2006 | Abandoned |